✦ LIBER ✦

Improved therapies for Parkinson's disease: life beyond dopamine D2D3 receptors agonists: D1 receptor agonists, dopamine uptake blockers and non-dopaminergic approaches to disease therapy

✍ Scribed by Michael Williams; Stephen Wright; G. Kenneth Lloyd

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dopamine agonists used in the treatment

✍ Jacques De Keyser; Jean-Paul De Backer; Nadine Wilczak; Luc Herroelen 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 539 KB

Dopamine D3 Receptor Agonist Delivery to

✍ Van Kampen, J. M. 📂 Article 📅 2006 🏛 Society for Neuroscience 🌐 English ⚖ 543 KB

Mechanisms and Issues Relating to the Us

✍ David E. Nichols; Mechelle M. Lewis 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 401 KB

The decrease of dopamine D2/D3 receptor

✍ Szabolcs Farkas; Katalin Nagy; Zhisheng Jia; Tibor Harkany; Miklós Palkovits; Se 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 745 KB